CLS vs OGN · P/E 44, rev $8.75B vs P/E 3.4, rev $3.02B
Celestica Inc. (CLS) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Celestica Inc. (CLS) is a electronic components company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CLS revenue for 2026-06-30 was $8.75B. Net income was $581.1M. CLS currently screens at market cap $17.99B and trailing P/E 43.6.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CLS currently screens at market cap $17.99B and trailing P/E 43.6. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CLS and OGN stock pages for the full models.
Not investment advice.